S

Shandong Boan Biotechnology Co Ltd
HKEX:6955

Watchlist Manager
Shandong Boan Biotechnology Co Ltd
HKEX:6955
Watchlist
Price: 8.2 HKD -3.53% Market Closed
Market Cap: 5.1B HKD

Wall Street
Price Targets

Price Targets Summary
Shandong Boan Biotechnology Co Ltd

There are no price targets for Shandong Boan Biotechnology Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Shandong Boan Biotechnology Co Ltd Competitors:
Price Targets
688382
InventisBio Co Ltd
84% Upside
ATRA
Atara Biotherapeutics Inc
13% Upside
SNDX
Syndax Pharmaceuticals Inc
88% Upside
AMRN
Amarin Corporation PLC
11% Downside
ALT
Altimmune Inc
436% Upside
OPK
OPKO Health Inc
195% Upside
1801
Innovent Biologics Inc
36% Upside

Revenue
Forecast

Revenue Estimate
Shandong Boan Biotechnology Co Ltd

For the last 3 years the compound annual growth rate for Shandong Boan Biotechnology Co Ltd's revenue is 66%. The projected CAGR for the next 2 years is 33%.

66%
Past Growth
33%
Estimated Growth
Estimates Accuracy
-13%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Shandong Boan Biotechnology Co Ltd

The compound annual growth rate of Shandong Boan Biotechnology Co Ltd's operating income for the next 2 years is 36%.

N/A
Past Growth
36%
Estimated Growth
Estimates Accuracy
56%
Average Beat

Net Income
Forecast

Net Income Estimate
Shandong Boan Biotechnology Co Ltd

The compound annual growth rate of Shandong Boan Biotechnology Co Ltd's net income for the next 2 years is 75%.

N/A
Past Growth
75%
Estimated Growth
Estimates Accuracy
-30%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shandong Boan Biotechnology Co Ltd's stock price target?
Not Available

Shandong Boan Biotechnology Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Shandong Boan Biotechnology Co Ltd's Revenue forecast?
Projected CAGR
33%

For the last 3 years the compound annual growth rate for Shandong Boan Biotechnology Co Ltd's revenue is 66%. The projected CAGR for the next 2 years is 33%.

What is Shandong Boan Biotechnology Co Ltd's Operating Income forecast?
Projected CAGR
36%

The compound annual growth rate of Shandong Boan Biotechnology Co Ltd's operating income for the next 2 years is 36%.

What is Shandong Boan Biotechnology Co Ltd's Net Income forecast?
Projected CAGR
75%

The compound annual growth rate of Shandong Boan Biotechnology Co Ltd's net income for the next 2 years is 75%.

Back to Top